欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号UK/H/1895/001
药品名称Sucrofer
活性成分
    • IRON SUCROSE sodium salt 20.0 mg/ml
剂型Solution for injection
上市许可持有人Claris Lifesciences (UK) Limited
参考成员国 - 产品名称United Kingdom (UK)
Sucrofer
互认成员国 - 产品名称
    • Latvia (LV)
    • Netherlands (NL)
    • Norway (NO)
    • Poland (PL)
    • Portugal (PT)
    • Sweden (SE)
    • Germany (DE)
      Sucrofer
    • Denmark (DK)
    • Estonia (EE)
    • France (FR)
    • Finland (FI)
    • Ireland (IE)
    • Lithuania (LT)
许可日期2015/11/06
最近更新日期2016/01/06
药物ATC编码
    • B03AC02 saccharated iron oxide
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
    市场状态Withdrawn（注：已撤市）
    撤市原因：1.The company decided to withdraw the application. At the time of withdrawal, the MS considered that the data provided did not allow to conclude on a positive benefit-risk balance as major objections were raised.
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase